These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21424067)

  • 21. Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
    Collins LC; Tamimi RM; Baer HJ; Connolly JL; Colditz GA; Schnitt SJ
    Cancer; 2005 May; 103(9):1778-84. PubMed ID: 15770688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of insulin-like growth factor II in female breast cancer as related to established prognostic factors and long-term prognosis.
    Toropainen EM; Lipponen PK; Syrjanen KJ
    Anticancer Res; 1995; 15(6B):2669-74. PubMed ID: 8669844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regression analysis of the initial karyometric data on tumor cells in ductal carcinoma and fibroadenoma of the mammary gland.
    Kirillov V; Akimova L
    Anal Quant Cytol Histol; 2010 Apr; 32(2):102-5. PubMed ID: 20701078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
    Xie F; Wang Q; Chen Y; Gu Y; Mao H; Zeng W; Zhang X
    Pathol Res Pract; 2010 Nov; 206(11):735-9. PubMed ID: 20634005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium.
    Moinfar F; Man YG; Bratthauer GL; Ratschek M; Tavassoli FA
    Cancer; 2000 May; 88(9):2072-81. PubMed ID: 10813719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
    Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
    Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear morphometry in FNABs of breast disease in Libyans.
    Abdalla F; Boder J; Buhmeida A; Hashmi H; Elzagheid A; Collan Y
    Anticancer Res; 2008; 28(6B):3985-9. PubMed ID: 19192660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Observations on the histopathologic diagnosis of microinvasive carcinoma of the breast.
    Prasad ML; Osborne MP; Hoda SA
    Anat Pathol; 1998; 3():209-32. PubMed ID: 10389587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
    Poller DN; Silverstein MJ; Galea M; Locker AP; Elston CW; Blamey RW; Ellis IO
    Mod Pathol; 1994 Feb; 7(2):257-62. PubMed ID: 7911998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium.
    Oliveira VM; Piato S; Silva MA
    Breast Cancer Res Treat; 2006 Feb; 95(3):235-41. PubMed ID: 16322898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclooxygenase-2 expression is related to nuclear grade in ductal carcinoma in situ and is increased in its normal adjacent epithelium.
    Shim V; Gauthier ML; Sudilovsky D; Mantei K; Chew KL; Moore DH; Cha I; Tlsty TD; Esserman LJ
    Cancer Res; 2003 May; 63(10):2347-50. PubMed ID: 12750248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between type and grade of ductal carcinoma in situ and concomitant invasive ductal carcinoma of the breast.
    Rudnicka L; Stachura J
    Pol J Pathol; 2000; 51(3):137-43. PubMed ID: 11247396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ductal carcinoma in situ of the breast (DCIS) with heterogeneity of nuclear grade: prognostic effects of quantitative nuclear assessment.
    Chapman JA; Miller NA; Lickley HL; Qian J; Christens-Barry WA; Fu Y; Yuan Y; Axelrod DE
    BMC Cancer; 2007 Sep; 7():174. PubMed ID: 17845726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative study of ductal breast cancer progression: nuclear signatures for evaluation of progression grade.
    Mombello A; Mariuzzi L; Morelli L; Granchelli G; Rucco V; Tarocco E; da Silva VD; Thompson D; Bartels HG; Bartels PH; Mariuzzi G
    Adv Clin Path; 2001 Jul; 5(3):59-70. PubMed ID: 11753877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of nuclear morphometry of breast cancer in histological sections with clinicopathological features and prognosis.
    Abdalla F; Boder J; Markus R; Hashmi H; Buhmeida A; Collan Y
    Anticancer Res; 2009 May; 29(5):1771-6. PubMed ID: 19443402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell proliferation in hyperplastic and in situ carcinoma lesions of the breast estimated by in vivo labeling with bromodeoxyuridine.
    Christov K; Chew KL; Ljung BM; Waldman FM; Goodson WH; Smith HS; Mayall BH
    J Cell Biochem Suppl; 1994; 19():165-72. PubMed ID: 7823588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience.
    Padmore RF; Fowble B; Hoffman J; Rosser C; Hanlon A; Patchefsky AS
    Cancer; 2000 Mar; 88(6):1403-9. PubMed ID: 10717623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear morphometry in prognostication of breast cancer in Saudi Arabian patients: comparison with European and African breast cancer.
    Buhmeida A; Al-Maghrabi J; Merdad A; Al-Thubaity F; Chaudhary A; Gari M; Abuzenadah A; Collan Y; Syrjänen K; Al-Qahtani M
    Anticancer Res; 2010 Jun; 30(6):2185-91. PubMed ID: 20651368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
    Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
    Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphometric analysis and p63 improve the identification of myoepithelial cells in breast lesion cytology.
    Aikawa E; Kawahara A; Kondo K; Hattori S; Kage M
    Diagn Cytopathol; 2011 Mar; 39(3):172-6. PubMed ID: 21319317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.